CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence

BACKGROUND: Multiple early gastric cancers (EGCs) may develop in 6–14% of patients even after achieving curative endoscopic submucosal dissection (ESD); however, a useful biomarker for predicting recurrence is not available. The present study investigated whether the expression of CD44 variant 9 (CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirata, K, Suzuki, H, Imaeda, H, Matsuzaki, J, Tsugawa, H, Nagano, O, Asakura, K, Saya, H, Hibi, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721391/
https://www.ncbi.nlm.nih.gov/pubmed/23778530
http://dx.doi.org/10.1038/bjc.2013.314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721391/
https://www.ncbi.nlm.nih.gov/pubmed/23778530
http://dx.doi.org/10.1038/bjc.2013.314

Ejemplares similares